3rd International Symposium on Regenerative Hepatology
Organized by: EASL Regenerative Hepatology Consortium
June 4, 2024 9:00-17:30
Venue:
CASA CARDINALE ILDEFONSO SCHUSTER
Via Sant’Antonio, 5 – 20122
Milan, Italy
Opening
9:00-9:10 – Welcome and opening of the symposium by Pedro Baptista, Etienne Sokal, Tobias Cantz and Bart Spee.
Gene Therapy/Editing and other Novel Therapies in Regenerative Hepatology
Moderator: Krista Rombouts, Institute for Liver and Digestive Health, UCL, London, UK.
9:10-9:40 – The development of novel therapies for Amyloidosis, Vittorio Bellotti, IRCCS Policlinico San Matteo, Pavia, Italy
9:40-10:10 – Prime time for gene-correction therapies targeting the liver, Sabine Fuchs, Utrecht University, Utrecht, The Netherlands
10:10-10:40 – Curing Crigler-Najar with Gene Therapy, Lorenzo D’Antiga, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
10:40-11:00 – Discussion
11:00-11:30 Coffee break
AI, Modeling and Simulation: The New Frontiers in Regenerative Hepatology
Moderator: Bart Spee, Utrecht University, Utrecht, The Netherlands
11:30-12:00 – Modeling liver regeneration and bile duct development in silico, Paul van Liedekerke, Ghent University, Ghent, Belgium
12:00-12:30 – AI liver allocation algorithms in liver transplantation, Patrizia Burra, University of Padova, Padova, Italy
12:30-13:00 – 3D spatially-resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression, Marino Zerial, Human Technopole, Milan, Italy
13:00-14:00 Lunch Break
Industry Session: Uncovering new products with potential in Regenerative Hepatology
Moderator: Pedro Baptista, IIS Aragon, Zaragoza, Spain.
14:00-14:10 – Easy and automated ex vivo liver perfusion with the gentleMACS™ Technology, Elaheh Soleimanpour, Miltenyi Biotec
14:10-14:20 – From Procurement to Application: Advanced Techniques in Liver Tissue and Cell Handling for Research and Therapeutics, Natalia Sanchez Romero, BeCytes Biotechnologies SL
14:20-14:30 – Optimised iPSC-derived hepatocytes (Opti-HEP) as a novel in vitro platform in drug efficacy and toxicity screening, Nikolaos Nikolaou, DefiniGEN Ltd.
14:30-14:40 – Bit.Bio
14:40-14:50 – A long-term perfusion platform to improve the standard of care, Andrea Venturato, Apersys AG
Poster session
15:00-16:00 – Rapid fire poster presentations (5 minutes for each presenter)
Regenerating Livers Left and Right: Bioengineering and Cell Therapies for the Liver
Moderators: Sara Campinoti, The Roger Williams Institute of Hepatology, London, UK.
Natalia Sanchez Romero, BeCytes Biotechnologies SL, Spain.
16:00 Bioengineering liver models for in vitro applications, Volker Lauschke, Karolinska Institute, Sweden
16:30 Bioengineering approaches for drug discovery, Alan Holmes, Engitix Therapeutics Ltd, London, UK.
17:00 Macrophage therapy for liver disease, Stuart Forbes, Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh, UK
17:30 Closure
___________________________________________________________________________
Abstract Submission
Abstract submission will be open from March 25th until May 25th.
Please submit your abstracts to: mail@regenerativehepatology.com
We will award a 1st prize of 150 EUR to the best poster.
Coffee breaks and lunch will be provided.
Registration
Please register at mail@regenerativehepatology.com before May 25, 2024.
REGISTRATION FEE: 75 EUR
Should be paid at:
Foundation for Regenerative Hepatology
Chamber of Commerce number: 80698247
Registered at: Luwte 6, de Meern, the Netherlands
Bank account number foundation: NL45 INGB 000 772 448 4
BIC/WIFT: INGBNL2A VAT number: NL861765904B01
Symposium Chair
Pedro Baptista
Organizers
Ludovic Vallier
Massimo Pinzani
Etienne Sokal
Bart Spee
Tobias Cantz
Frederic Lemaigre
Event Sponsors
Institutional Sponsors
Gold Sponsors
Bronze Sponsors
